These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 5550888)

  • 41. Prognosis and therapy of complex partial seizures with barbiturates, hydantoins, and other drugs.
    Tassinari CA; Roger J
    Adv Neurol; 1975; 11():201-19. PubMed ID: 3105
    [No Abstract]   [Full Text] [Related]  

  • 42. The effects of chronic drug administration on hepatic enzyme induction and folate metabolism.
    Labadarios D; Dickerson JW; Parke DV; Lucas EG; Obuwa GH
    Br J Clin Pharmacol; 1978 Feb; 5(2):167-73. PubMed ID: 23138
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Induction of hepatic enzymes during normal human pregnancy.
    Davis M; Simmons CJ; Dordoni B; Maxwell JD; Williams R
    J Obstet Gynaecol Br Commonw; 1973 Aug; 80(8):690-4. PubMed ID: 4725945
    [No Abstract]   [Full Text] [Related]  

  • 44. [Phenobarbital treatment of indirect hyperbilirubinemia states in various hepatic diseases].
    Del Rio A; Noya M; De Oya JC
    Rev Clin Esp; 1972 Mar; 124(5):459-62. PubMed ID: 5034133
    [No Abstract]   [Full Text] [Related]  

  • 45. Hepatic microsomal enzyme induction: treatment of vitamin D poisoning in a 7 month old baby.
    Lukaszkiewicz J; Prószyńska K; Lorenc RS; Ludwiczak H
    Br Med J (Clin Res Ed); 1987 Nov; 295(6607):1173. PubMed ID: 3120931
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of unconjugated jaundice with dicophane.
    Thompson RP; Stathers GM; Pilcher CW; McLean AE
    Lancet; 1969 Jul; 2(7610):4-6. PubMed ID: 4182808
    [No Abstract]   [Full Text] [Related]  

  • 47. [The advantages of benzonal as an inducer of the liver mono-oxygenase enzyme system compared to phenobarbital].
    Nadzhimutdinov KN; Khakimov ZZ; Kabulov ShM
    Eksp Klin Farmakol; 1992; 55(1):68-71. PubMed ID: 1305441
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of phenobarbitone on hepatic drug-metabolizing enzymes and urinary D-glucaric acid excretion in man.
    Lecamwasam DS; Franklin C; Turner P
    Br J Clin Pharmacol; 1975 Jun; 2(3):257-62. PubMed ID: 1234506
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Clinical and biochemical studies in the Crigler-Najjar syndrome].
    Kline W; Rosenkranz A
    Monatsschr Kinderheilkd (1902); 1971 Oct; 119(10):555-8. PubMed ID: 5116339
    [No Abstract]   [Full Text] [Related]  

  • 50. Controlled trial of phetharbital, a non-hypnotic barbiturate, in unconugated hyperbilirubinaemia.
    Hunter J; Thompson RP; Rake MO; Williams R
    Br Med J; 1971 May; 2(5760):497-9. PubMed ID: 4931488
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of low-dose phenobarbitone on three indices of hepatic microsomal enzyme induction.
    Price DE; Mehta A; Park BK; Hay A; Feely MP
    Br J Clin Pharmacol; 1986 Dec; 22(6):744-7. PubMed ID: 3567022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [General review of the present therapy of epilepsy].
    Ristić J
    Neuropsihijatrija; 1971; 19(1):5-19. PubMed ID: 4948996
    [No Abstract]   [Full Text] [Related]  

  • 53. [Current problems in the hyperbilirubinemia of premature infants].
    Rosanelli K
    Monatsschr Kinderheilkd (1902); 1972 Sep; 120(9):354-62. PubMed ID: 4563170
    [No Abstract]   [Full Text] [Related]  

  • 54. Increased urinary D-glucaric acid excretion by children living in an area polluted with tetrachlorodibenzoparadioxin (TCDD).
    Ideo G; Bellati G; Bellobuono A; Mocarelli P; Marocchi A; Brambilla P
    Clin Chim Acta; 1982 Apr; 120(3):273-83. PubMed ID: 7074964
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Measurement of urinary 6-beta-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme-inducing capacity of antipyrine, phenobarbitone and rifampicin.
    Ohnhaus EE; Park BK
    Eur J Clin Pharmacol; 1979 Mar; 15(2):139-45. PubMed ID: 35353
    [No Abstract]   [Full Text] [Related]  

  • 56. [A study of some indirect biochemical markers in the evaluation of enzymatic induction caused by antiepileptic drugs].
    Tutor-Crespo MJ; Hermida-Ameijeiras J; Tutor-Valcarce JC
    Rev Neurol; 2002 Oct 16-31; 35(8):711-6. PubMed ID: 12402220
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical implications of enzyme induction.
    Breckenridge A
    Basic Life Sci; 1975; 6():273-301. PubMed ID: 239673
    [No Abstract]   [Full Text] [Related]  

  • 58. Microsomal enzyme induction by drugs.
    Conney AH
    Pharmacol Physicians; 1969 Dec; 3(12):1-5. PubMed ID: 4187011
    [No Abstract]   [Full Text] [Related]  

  • 59. [Optimisation of epilepsy monotherapy (clinico-pharmacological study)].
    Gromov SA; Khorshev SK
    Zh Nevrol Psikhiatr Im S S Korsakova; 1997; 97(7):31-5. PubMed ID: 9511212
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment.
    Hermida J; Fernández MP; Tutor JC
    Clin Lab; 2002; 48(7-8):415-9. PubMed ID: 12146576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.